Urge Incontinence

rTMS in Overactive Bladder

Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in Women

Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement

Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial

Percutaneous Nerve Evaluation Trial Time

A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections

A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

Effectiveness of eCoin at Sensory and Subsensory Amplitudes

Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence

UCon Treatment of Overactive Bladder (OAB) in Males

Assessing the Genitourinary Microbiome of Women With Overactive Bladder Undergoing Onabotulinum Toxin Type A Intradetrusor Injections

High Intensity Focused Electromagnetic Field Device for Urinary Incontinence

Central Nervous System Changes Following OnabotulinumtoxinA Injection in the Bladder

A Group-Based Therapeutic Yoga Intervention for Urinary Incontinence in Ambulatory Older Women

Minimizing Pain During Office Intradetrussor Botox Injection

Lidocaine Patches Prior to Percutaneous Nerve Evaluation

Social Media Navigation Aid Kits for Urinary Incontinence

Efficacy of Surface Electrical Stimulation for Urge Urinary Incontinence in Women

Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections

A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder